Mentari Therapeutics
1 known investors
Mentari Therapeutics develops targeted biological therapies for migraine treatment, focusing on PACAP pathway inhibition through monoclonal and bispecific antibodies for patients with inadequate relief from existing anti-CGRP therapies.
Investors · 1
Competitors · 3
by search overlapflagship pioneering3 shared keywordsFlagship Pioneering is a firm that builds and funds companies in life sciences and related fields, describing itself as focused on breakthroughs for people and the planet.
Montara Therapeutics3 shared keywordsMontara is a biotech company developing small-molecule therapeutics focused on neurodegeneration and diseases such as Alzheimer's. It was founded by scientists whose prior company, Mitokinin, was acquired by AbbVie in 2023.
Muna Therapeutics3 shared keywordsMuna Therapeutics is a biotechnology company that discovers and develops therapies aimed at slowing or stopping neurodegenerative diseases, including Alzheimer's and Parkinson's. It operates in neurology-focused drug discovery and development.
Companies competing with Mentari Therapeutics for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Mentari Therapeutics do?
- Mentari Therapeutics develops targeted biological therapies for migraine treatment, focusing on PACAP pathway inhibition through monoclonal and bispecific antibodies for patients with inadequate relief from existing anti-CGRP therapies.
- Who are Mentari Therapeutics's investors?
- Mentari Therapeutics's investors include Andreessen Horowitz.